NFE2L2 and Obesity: Slocum et al. demonstrated that a Keap1-hypo mouse model with Nrf2 pathway activation suppressed high-fat diet-induced (60 kcal% fat) obesity and decreased deposition of lipids and cholesterol in the liver [86].